Compare Cytokinetics Inc (CYTK) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Vanguard Short Term Corporate Bond ETF trades at $78.52. The key difference: Cytokinetics Inc is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| CYTK | VCSH | |
|---|---|---|
Market Cap | $10.63B | — |
Sector | Technology | Fixed Income |
52-Week High | $87.26 | $80.20 |
52-Week Low | $34.31 | $78.41 |
Enterprise Value | $10.74B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
